Wire Stories
IASO Biotherapeutics Publishes Preclinical Results of Its CD5-Targeting CAR-T in American Society of Gene & Cell Therapy�s Journal, Molecular Therapy
PLEASANTON, Calif. & NANJING, China & SHANGHAI–(BUSINESS WIRE)–#Biopharmaceutical—IASO Biotherapeutics (IASO Bio), a clinical-stage biopharmaceutical company advancing the development of novel cell therapies...